Haemonetics Corporation
HAEMedical Devices
$119.65−0.12%As of Oct 30vs prior close
- Market cap
- $5.4B
- P/E (TTM)
- 57.5×
- P/E (FY1)
- 22.5×
- From 52W high
- −1.97%
- EPS (LTM)
- $2.07
- Revenue (LTM)
- $1.4B
- Net margin
- 7.12%
- Dividend yield
- 0.00%
Nomior Score
66
Emerging BreakoutSpeculativeTop 15% of the scored universe
Growth46
Quality75
Value52
Momentum88
Resilience39
Growth
+4.65%revenue a year over 9 fiscal years
YE17 $886.1MLTM $1.4B
Connections
Revenue to profitQ1 YE27
10% of revenue became net profit, down 1 pt on a year.
Who owns it
3funds, 1 tracked portfolio